ATCC Breast Cancer Research Resources

4/24/2014


Breast cancer is the leading cause of cancer-related mortality in women. New disease classifications, relevant signaling pathways, and genetic regulators of breast cancer have been identified over the past decade. To continue facilitating progress in basic research and drug discovery, ATCC provides breast cancer research resources. In this webinar, we will discuss triple negative breast cancer cell lines, breast cancer mouse models, and commonly used breast cancer in vitro models with in-depth genetic alteration and molecular profiles. We will also highlight cell lines that can be used to address recently identified genomic and clinical features of breast cancer subtypes.

Presenters

Fang Tian, Ph.D.

Fang Tian, Ph.D.,
Lead Scientist, ATCC Cell Systems

Dr. Fang Tian, Lead Scientist, head of the Translational Cell Biology Group for ATCC Cell Systems, has extensive experience in cell biology and molecular biology. She oversees human, animal cell lines and hybridomas, and product development in the Cell Biology General Collection at ATCC. Dr. Tian was a research fellow in Massachusetts General Hospital, Harvard Medical School. She conducted postdoctoral research at the Hillman Cancer Institute of UPMC.